Galectin Therapeutics, Inc. (GALT)
4.38
-1.78
(-28.90%)
USD |
NASDAQ |
Dec 19, 16:00
4.31
-0.07
(-1.60%)
Pre-Market: 08:19
Galectin Therapeutics Total Liabilities (Quarterly): 136.44M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
| Theriva Biologics, Inc. | 24.10M |
| Oragenics, Inc. | 2.874M |
| NanoViricides, Inc. | 1.182M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.86M |
| Shareholders Equity (Quarterly) | -123.58M |
| Debt to Equity Ratio | -0.9897 |
| Current Ratio | 0.0933 |
| Net Debt Paydown Yield | -2.11% |